Avenue Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Accounts Payable and Accrued Expenses

12 Months Ended

Dec. 31, 2022

Note 5 — Accounts Payable and Accrued Expenses

Accounts payable, accrued expenses and other liabilities consisted of the following (in thousands):


	As of December 31,
	2022		2021
Accounts payable	$	129	$	304
Accrued employee compensation		199		24
InvaGen contingent fee		208		—
Accrued contracted services and other		413		123
Accounts payable and accrued expenses	$	949	$	451